// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Substantial implications for study numbers based on typical study populations, using different MRI slice thickness for bone shape and cartilage thickness: data from the osteoarthritis initiative

M.A. Bowes - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Method for co-registration of high resolution 3Tmagnetic resonance imaging with standing 0.5T magnetic resonance imagingto investigate weight bearing joints

E. Peake - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interleukin-17 is a potential contributor to the inflammatory environment in the OA joint

J.Y. Mimpen - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin

Determinants of osteoarthritis 3D bone shape and it’s change in the three knee bones: a latent growth modelling approach on 37 583 MR images from the osteoarthritis initiative

B. Dube - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Do changes in feature selection parameters influence the classification of knee rehabilitation exercises when using body worn accelerometer data?

P. Jones - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association of bone marrow lesions localisation with weight bearing pain in people with knee osteoarthritis: data from the osteoarthritis initiative

K. Aso - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Synovial fluid cytokines and adipokines as predictors of poor outcome in total HIP and knee joint replacement in patients with osteoarthritis

D.E. Nanus - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Angiotensin 2 type 2 receptor blockade is a novel target for murine osteoarthritis pain

I.S. von Loga - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Angiotensin II

Inferiority of laboras over incapacitance testing to measure spontaneous murine osteoarthritis pain

I.S. von Loga - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory Arthritis

N/A

Populated collagen hydrogel and polyhydroxyalkanoate composites: novel matrices for cartilage repair and regeneration?

C. De Pascale - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Human umbilical cord mesenchymal stromal cells do not evoke an immune response in the partial medial meniscectomy murine model of osteoarthritis

J. Perry - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Interferon Gamma

Using a mouse model of osteochondral injury to understand bone and articular cartilage repair

F.E. Beaton - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A qualitative evaluation of physiotherapists acceptability of a clinical sensor based approach to movement feedback rehabilitation

K.A. Nicholas - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Foot and leg muscle weakness in individuals with midfoot pain and osteoarthritis

J.B. Arnold - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Does baseline and change in lower extremity lean and fat composition over 5 years predict the incidence of radiographic knee osteoarthritis in women?

P. Krishnasamy - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Subgrouping and targeted exercise programmes for knee and hip osteoarthritis (STEER OA) individual participant data meta-analysis. Progress update and selection of potential moderators for analyses

M.A. Holden - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Comparison microRNAs expression in normal and ruptured canine cruciate ligaments

Y.Ashraf Kharaz - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical effectiveness of enhanced exercise therapy for adults with knee osteoarthritis. 3 year follow-up a randomised controlled trial (the BEEP trial)

N.E. Foster - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Effects of skin cooling on intra-articular knee temperature in healthy subjects

R.M. Stevens - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epinephrine

The association between comorbidity and physical activity levels in people with osteoarthritis: secondary analysis from two randomised controlled trials

S. Mckevitt - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved